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Introduction
The accurate replication of our genome is an essential require-
ment for the high-fidelity transmission of genetic information 
to daughter cells. DNA replication forks are constantly chal-
lenged and arrested by DNA lesions, induced by endogenous 
and exogenous agents, and by a diverse range of intrinsic repli-
cation fork obstacles, such as transcribing RNA polymerases, 
unusual DNA structures or tightly bound protein–DNA com-
plexes (Carr and Lambert, 2013). An emerging model of how 
stalled or damaged forks are processed is that replication forks 
can reverse to aid repair of the damage (Atkinson and McGlynn, 
2009; Ray Chaudhuri et al., 2012; Berti et al., 2013). This model 
implies significant remodeling of replication fork structures into 
four-way junctions and the molecular determinants required for 
reversed fork processing and restart are just beginning to be 
elucidated. The first evidence that supports the physiological re-
levance of this DNA transaction during replication stress in 
human cells arose from studies with DNA topoisomerase I 
(TOP1) inhibitors (Ray Chaudhuri et al., 2012). Additional 
studies established that the human RECQ1 helicase promotes 
the restart of replication forks that have reversed upon TOP1 
inhibition by virtue of its ATPase and branch migration activi-
ties (Berti et al., 2013). These observations were recently ex-
tended to show that the RECQ1 mechanism of reversed fork 
restart is a more general response to a wide variety of replica-
tion challenges (Zellweger et al., 2015). Nonetheless, new lines 
of evidence point to alternative mechanisms and factors that 
might mediate either formation or processing of reversed repli-
cation forks (Bétous et al., 2012; Gari et al., 2008). These puta-
tive mechanisms likely include nucleases that are capable of 
processing stalled replication intermediates upon genotoxic 
stress (Cotta-Ramusino et al., 2005; Schlacher et al., 2011; 
Hu et al., 2012; Ying et al., 2012).
Here, we investigate the contribution of the human DNA2 
nuclease/helicase in reversed fork processing. DNA2 is a highly 
conserved nuclease/helicase initially identified in Saccharomyces 
cerevisiae screening for mutants deficient in DNA replication 
(Kuo et al., 1983; Budd and Campbell, 1995). Yeast Dna2 plays 
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single-molecule DNA fiber replication assays. We pulse- 
labeled human osteosarcoma (U-2 OS) cells with the thymidine 
analogue CldU for 20 min, followed by a 60-min exposure to a 
selected genotoxic agent during the CldU labeling period, and 
by labeling with the second thymidine analogue, IdU, for an ad-
ditional 40 min after removal of the genotoxic drug. We found 
that DNA2 plays an important role in restarting replication 
forks after treatment with the ribonucleotide reductase inhibitor 
hydroxyurea (HU), the topoisomerase I inhibitor camptothecin 
(CPT), and the interstrand cross-linking agent mitomycin C 
(MMC) (Fig. 1 A). In addition, DNA2 depletion increased the 
percentage of origin firing, but not of fork termination events 
(Fig. S1 A). Genetic knockdown–rescue experiments confirmed 
that complementation in DNA2-depleted U-2 OS cells with 
siRNA-resistant WT DNA2 abrogated the effect of DNA2 de-
pletion on replication fork restart upon HU treatment. More-
over, expression of the nuclease-deficient DNA2 mutant D294A 
in DNA2-depleted cells revealed that the nuclease activity 
of DNA2 was essential for its role in replication fork restart 
(Fig. 1 B and Fig. S1 B).
We next measured whether DNA2 uses its nuclease activ-
ity to process stalled replication intermediates by monitoring 
the integrity of the newly synthesized DNA after HU treatment. 
To this purpose, we changed the DNA labeling scheme. We first 
pulsed U-2 OS cells with IdU for 45 min, and then varied the 
exposure time to HU from 0 to 8 h. The mean length of the IdU 
tracts progressively decreased during HU treatment from 18.2 µm 
(0 h) to 12.0 µm (8 h; Fig. 1 C). However, shRNA-mediated 
DNA2 depletion largely prevented IdU tract shortening, con-
firming that DNA2 is responsible for the observed nascent 
strand degradation (Fig. 1 D). Double-labeling experiments 
confirmed that the observed nascent tract shortening is indeed 
caused by the DNA2-dependent processing of ongoing replica-
tion forks and that this degradation is important to mediate ef-
ficient replication fork restart upon prolonged HU treatment 
(Fig. 1 E). Clonogenic analysis of U-2 OS cells treated with the 
same HU concentration used for the DNA fiber experiments 
showed a significantly reduced cell survival upon DNA2 deple-
tion, indicating that the DNA2-dependent processing of stalled 
replication intermediates is critical for recovery from replica-
tion fork blockage (Fig. 2 A). The results obtained with the 
shRNA DNA2-depleted U-2 OS cells were validated using a 
new conditional knockout human colorectal carcinoma cell line 
(HCT116) where addition of tamoxifen to the culture medium 
led to DNA2-null cells. Analysis of the mean tract lengths con-
firmed that DNA2 knockout in HCT116 cells abrogates the 
prominent degradation observed upon HU treatment (Fig. 2 B). 
Collectively, these results indicate that human DNA2 degrades 
nascent strands at stalled replication forks to facilitate fork re-
start and promote viability after genotoxic stress induction.
RECQ1 regulates the fork processing 
activity of DNA2
On the basis of the recent discovery that RECQ1 is required to 
restart replication forks that have reversed upon genotoxic stress 
induction (Berti et al., 2013), we investigated whether RECQ1 
regulates the fork processing activity of DNA2. Nascent IdU 
an essential role in Okazaki fragment maturation during lagging 
strand DNA replication (Budd and Campbell, 1997; Bae et al., 
2001; Ayyagari et al., 2003). However, increasing evidence sug-
gests that DNA2 has important—albeit yet undefined—roles in 
DNA replication stress response and DNA repair, which go be-
yond its postulated role in Okazaki fragment processing (Duxin 
et al., 2012; Karanja et al., 2012; Peng et al., 2012). The notion 
that DNA2 is important for DNA replication is strengthened by 
the observation that DNA2 forms a complex with various repli-
cation core components, including the replisome protein And-1 
(Wawrousek et al., 2010; Duxin et al., 2012). Moreover, human 
DNA2 seems to play a partially redundant role with human exo-
nuclease I (EXO1) in replication-coupled repair (Karanja et al., 
2012), whereas a recent study in S. pombe suggested that the 
nuclease activity of DNA2 is required to prevent stalled forks 
from reversing upon HU treatment (Hu et al., 2012).
DNA2 also has an independent function in dsDNA break re-
pair. Two distinct pathways act redundantly to mediate processive 
DSB resection downstream from the MRE11-RAD50-NBS1 
(MRN) and CtIP factors in eukaryotic cells: one requires DNA2 
and the other EXO1 (Gravel et al., 2008; Mimitou and Symington, 
2008; Zhu et al., 2008; Nicolette et al., 2010). Specifically, DNA2 
and EXO1 resect the 5 ends of double-strand DNA breaks (DSBs) 
to generate 3 single-stranded overhangs, which are essential to 
initiate homologous recombination. In yeast, DNA2-dependent 
dsDNA-end resection reaction requires the Sgs1 helicase to un-
wind the DNA from the break (Zhu et al., 2008; Cejka et al., 2010; 
Niu et al., 2010). This mechanism appears to be largely conserved 
in mammalian cells where DNA2 cooperates with the human BLM 
helicase to resect dsDNA ends in vitro (Nimonkar et al., 2011). 
However, mammalian cells possess five human RecQ homologues 
(RECQ1, RECQ4, RECQ5, BLM, and WRN) and WRN can also 
assist DNA2-dependent end resection, suggesting that BLM might 
not be the sole RecQ homologue required for this process (Liao 
et al., 2008; Sturzenegger et al., 2014). The ability of DNA2 and 
EXO1 to process dsDNA ends might also be relevant in the con-
text of DNA replication to prevent the accumulation of replica-
tion-associated DSBs by promoting homologous recombination 
(HR) repair (Peng et al., 2012). Alternatively, these nucleases 
might be involved in the recovery of replication fork blockage 
by processing specific stalled replication fork structures.
This work uncovers a new DNA2- and WRN-dependent 
mechanism that mammalian cells use to process replication 
forks that have reversed as a result of replication inhibition. Im-
portantly, it also shows that this mechanism is tightly regulated 
by human RECQ1 and the HR factor RAD51. Our observations 
shed light on a novel pathway for the suppression of chromo-
somal instability in mammalian cells and provide important 
new insight into the mechanisms of replication stress response 
associated with chemotherapeutic drug damage.
Results
DNA2 is required for stalled fork 
processing and restart
To begin elucidating the role of human DNA2 during replication 
stress, we monitored replication perturbation by genome-wide 
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Figure 1. DNA2 is required for replication fork restart and stalled fork processing upon genotoxic stress. (A) Schematic of DNA fiber tract analysis. 
U-2 OS cells were transfected with control siRNA or DNA2 siRNA before CldU or IdU labeling. Red tracts, CldU; curved red tracts, CldU with genotoxic agents 
(HU or CPT or MMC); green tracts, IdU. (bottom) Representative DNA fiber image. (right) quantification of red-green contiguous tracts (restarting forks). 
Mean shown, n = 3. Error bars, standard error. ns, not significant; *, P < 0.05; **, P < 0.01 (paired t test). (B) Quantification of restarting forks in DNA2-
depleted cells expressing DNA-WT or DNA2-D294A. ns, not significant; *, P < 0.05 (paired Student’s t test). (C, top) Representative DNA fiber image. 
(bottom) Representative IdU tract length distributions in Luc-depleted cells during different exposure time to HU (out of 3 repeats; n ≥ 300 tracts scored 
for each dataset). Mean tract lengths are indicated in parentheses. (D) Top, DNA2 expression after shRNA knockdown. Bottom, representative IdU tracts 
in DNA2-depleted U-2 OS cells in the presence or absence of HU (out of 2 repeats; n ≥ 700 scored for each dataset). (E, left) Representative DNA fiber 
images. (middle) Quantification of red-green contiguous tracts (restarting forks) after 8 h of HU. Mean shown, n = 3. Error bars, standard error. **, P < 
0.01 (paired Student’s t test). (right) Statistical analysis of CldU tracts detected within contiguous red-green tracts. Whiskers the 10th and 90th percentiles. 
****, P < 0.0001 (Mann-Whitney test).
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Genetic knockdown–rescue experiments confirmed that 
complementation in RECQ1-depleted U-2 OS cells with shRNA-
resistant WT RECQ1 abrogates the effect of RECQ1 depletion 
on replication fork processing upon HU treatment (Fig. 3 F). 
Interestingly, expression of the ATPase-deficient RECQ1 mutant 
K119R in RECQ1-depleted cells also abrogated the effect of 
RECQ1 depletion indicating that the ATPase activity of RECQ1 
was not required for its role in protecting stalled forks from 
DNA2-dependent degradation (Fig. 3 F). These results point to 
an additional role of RECQ1 in protecting replication forks 
from extensive DNA2-dependent degradation, which is inde-
pendent of RECQ1 ATPase activity.
tracts were substantially shorter in RECQ1-depleted cells com-
pared with control when replication forks were stalled with HU 
(after 8 h of HU treatment, the mean tract lengths were 7.9 and 
12.0 µm, respectively; P < 0.0001; Fig. 3, A and B). In agree-
ment with results from luciferase-depleted cells, DNA2 was 
also responsible for the nascent strand degradation phenotype 
observed in RECQ1-deficient U-2 OS cells (Fig. 3 C). Analo-
gous results were obtained using the conditional DNA2 knock-
out HCT116 cell line (Fig. 2 C). In addition, we confirmed that 
the DNA2-dependent nascent strand degradation observed in 
the absence of RECQ1 is not limited to a specific replication in-
hibitor by replacing HU with CPT or MMC (Fig. 3, D and E).
Figure 2. DNA2 processes stalled replication forks. (A, top) DNA2 expression after siRNA knockdown. (bottom) Colony-forming assays in control and 
DNA2-depleted U-2 OS cells treated with 4 mM HU for the indicated time. (B) Representative IdU tracts in DNA2 conditional knockout HCT116 cells (out 
of two repeats). Tamoxifen was added to generate conditional knockout cells (see Materials and methods). (C, left) Expression of DNA2 and RECQ1 in 
tamoxifen-treated HCT116 cells. Right, representative IdU tracts in DNA2 conditional knockout HCT116 cells depleted for Luc or RECQ1 (out of three 
repeats). n ≥ 300 tracts scored for each dataset shown in B and C.
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Figure 3. RECQ1 regulates the DNA2-dependent degradation of stalled forks. (A) Representative IdU tracts in RECQ1-depleted U-2 OS cells during different 
exposure time to HU (out of 2 repeats; n ≥ 350 tracts scored for each dataset). (B) Bar graph represents the mean values of each time point from Figs. 1 C and 2 A. 
(top) RECQ1 expression after shRNA knockdown. (C, D, and E) Representative IdU tracts in RECQ1-, DNA2-, or RECQ1/DNA2-codepleted U-2 OS cells in the 
presence of HU (C), CPT (D), and MMC (E; out of 2 repeats; n ≥ 300 tracts scored for each dataset).(top) RECQ1 and DNA2 expression after shRNA or siRNA 
knockdown. (F) Representative IdU tracts in RECQ1-depleted U-2 OS cells complemented with shRNA-resistant WT RECQ1 (WT) or ATPase-deficient (K119R) 
RECQ1 (out of 2 repeats; n ≥ 325 tracts scored for each dataset). (top) Expression of Flag-tagged RECQ1-WT and RECQ1-K119R in RECQ1-depleted cells.
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part of the WRN:DNA2 complex. Collectively, these results 
suggest that DNA2 cooperates with WRN to promote nascent 
strand processing and fork restart after HU treatment.
The nuclease activity of DNA2  
and the ATPase activity of WRN are 
essential to process stalled replication forks
DNA2 is characterized by an N-terminal nuclease domain and 
by a C-terminal helicase domain, but the function of its helicase 
activity is still debated (Masuda-Sasa et al., 2006). To assess the 
roles of these two activities in stalled fork processing, we per-
formed genetic knockdown-rescue experiments where we de-
pleted DNA2 and then attempted to rescue fork processing by 
expressing a Flag-tagged siRNA resistant WT DNA2 control, 
nuclease-deficient DNA2-D294A, or ATPase-deficient DNA2-
K671E. All the experiments were performed in RECQ1-depleted 
cells, where the effect of DNA2 is more apparent. DNA fiber 
analysis showed that complementation with nuclease-deficient 
DNA2 prevents fork processing, whereas complementation 
with WT or ATPase-deficient DNA2 leads to the same fork pro-
cessing phenotype observed in DNA2-proficient cells (Fig. 5 D 
and Fig. S2 C). Therefore, the nuclease, but not the ATPase ac-
tivity of DNA2, is necessary for fork processing.
Next, we used a Werner Syndrome (WS) fibroblast cell 
line (AG11395) expressing missense mutant forms of WRN, 
which inactivate either the exonuclease (WRN-E84A) or the 
ATPase (K577M) activity of WRN (Pirzio et al., 2008). The 
ATPase, but not the nuclease activity of WRN, was important 
for fork processing (Fig. 5 E and Fig. S2 D). These findings 
were validated by genetic knockdown-rescue experiments where 
we complemented WRN-depleted U-2 OS cells either with 
an shRNA resistant WT WRN control or the ATPase-deficient 
WRN-K577M mutant and found that complementation with 
the ATPase-deficient mutant prevented fork processing (Fig. S2, 
E and F). Collectively, these results show that human DNA2 
needs the support of the ATPase activity of WRN to promote 
degradation of the nascent DNA strands.
DNA2 processes reversed replication forks
To gain insight into the actual replication structures processed 
by DNA2, we inspected the fine architecture of the replication 
intermediates using a combination of in vivo psoralen cross-
linking and EM (Neelsen et al., 2014). Our analysis showed 
a substantial fraction of reversed replication forks (24% of 
molecules analyzed) in control U-2 OS cells treated with 4 mM 
HU. RECQ1-depletion, and to an even greater extent DNA2-
depletion, resulted in a higher frequency of fork reversal events 
(30 and 40%, respectively) compared with HU-treated cells. 
Co-depletion of RECQ1 and DNA2 further increased the fre-
quency of reversed forks (50%), suggesting that RECQ1 and 
DNA2 are involved into two distinct mechanisms of reversed 
fork processing. Interestingly, RECQ1 and/or DNA2 depletion 
also led to a significant amount of fork reversal events in unper-
turbed U-2 OS cells (Fig. 6, A and B). WRN-depletion pheno-
copied DNA2-depletion in terms of reversed fork accumulation, 
both the presence and in the absence of HU. Moreover, DNA2/
DNA2 function in stalled fork processing  
is distinct from EXO1, Mre11, and CtIP
Next, we tested whether other nucleases share a function similar 
to DNA2 in stalled fork processing. To address this point, we 
depleted Mre11, EXO1, and CtIP in U-2 OS cells with siRNA-
mediated technologies. We found that none of these nucleases 
share the same phenotype of DNA2 in RECQ1-proficient cells 
(Fig. 4 A). Furthermore, depletion of these nucleases had only a 
marginal effect on the rescue of the prominent nascent strand 
degradation phenotype observed in the absence of RECQ1, indi-
cating that DNA2 has a unique function in reversed fork pro-
cessing that is not shared by these human nucleases (Fig. 4, B–D). 
MUS81 is another structure-specific nuclease that plays a critical 
role in replication fork rescue by converting stalled replication 
forks into DNA DSBs that can be processed by Homology Di-
rected Repair (HDR) (Hanada et al., 2007; Franchitto et al., 
2008). This raised the possibility that the DNA2-dependent 
degradation originated from the processing of MUS81-dependent 
DSBs. However, MUS81 depletion did not prevent nascent 
strand degradation, indicating that DNA2 is not processing 
stalled replication intermediates that are cleaved by MUS81 
(Fig. 4 E).
DNA2 and WRN act together to process 
stalled replication forks
DNA2-dependent dsDNA-end resection needs the support of 
a RecQ helicase to unwind the DNA from the break (Cejka 
et al., 2010; Niu et al., 2010; Nimonkar et al., 2011). To deter-
mine the identity of the helicase that acts in conjunction with 
DNA2 in stalled fork processing, we measured the extent of na-
scent strand degradation in BLM-, WRN-, and RECQ4-depleted 
U-2 OS cells. Our DNA fiber analysis showed that WRN deple-
tion mimicked the effect of DNA2-depletion, completely abro-
gating the prominent nascent strand degradation phenotype 
observed in RECQ1-depleted U-2 OS cells (Fig. 5 A). The same 
results were confirmed using WRN and DNA2 codepleted cells, 
suggesting that DNA2 and WRN are epistatic in nucleolytic 
processing of stalled forks (Fig. S1 C). The partial nascent 
strand degradation observed in RECQ1-proficient U-2 OS cells 
was also abrogated by WRN depletion (Fig. S1 D). Conversely, 
BLM depletion had only a marginal effect on the nascent strand 
degradation phenotype observed in RECQ1-depleted cells, 
whereas RECQ4 depletion had no effect (Fig. S2, A and B). Thus, 
the WRN helicase plays a prominent role in assisting DNA2-
dependent degradation of stalled replication forks.
We next compared the percentage of restarting replication 
forks in DNA2-depleted, WRN-depleted, and DNA2/WRN-
codepleted cells. WRN depletion leads to a decrease in restart-
ing forks (69 to 50%; P = 0.0068). These results are almost 
identical to those obtained with the DNA2-depleted or DNA2/
WRN-codepleted cells, implying that WRN and DNA2 are 
epistatic also in the restart process (Fig. 5 B). The notion that 
DNA2 and WRN functionally interact to process stalled repli-
cation intermediates is further supported by our observation that 
the two proteins form a complex both in the presence and ab-
sence of replication stress (Fig. 5 C). Of note, RECQ1 is not 
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Figure 4. EXO1, MRE11, CtIP, and MUS81 depletion does not affect stalled fork processing. (A) Statistical analysis of IdU tracts from U-2 OS cells depleted 
for the indicated proteins in the presence of 4 mM HU. (B) Representative IdU tracts in control, RECQ1-, MRE11-, or RECQ1/MRE11-codepleted U-2 
OS cells (out of 2 repeats). (top) Expression of RECQ1 and MRE11 after siRNA knockdown. (C) Representative IdU tracts in control, RECQ1-, EXO1-, or 
RECQ1/EXO1-codepleted U-2 OS cells (out of 2 repeats). (top) Expression of RECQ1 and EXO1 after siRNA knockdown. (D) Representative IdU tracts in 
control, RECQ1-, CtIP-, or RECQ1/CtIP-codepleted U-2 OS cells (out of 2 repeats). (top) Expression of RECQ1 and CtIP after siRNA knockdown. 
(E) Representative IdU tracts in Luc-, RECQ1-, MUS81-, or RECQ1/MUS81-codepleted U-2 OS cells in the presence of HU (out of 2 repeats). (left) Expres-
sion of RECQ1 and MUS81 after shRNA knockdown. n ≥ 300 tracts scored for each dataset shown in A–E.
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Figure 5. DNA2 and WRN are epistatic in stalled fork processing and replication restart. (A) Representative IdU tracts in RECQ1-, WRN-, or RECQ1/
WRN-codepleted U-2 OS cells (out of 2 repeats; n ≥ 300 tracts scored for each dataset). (top) RECQ1 and WRN expression after shRNA knockdown. 
(B) Quantification of restarting forks in DNA2-, WRN-, or DNA2/WRN-codepleted cells. Mean shown, n = 3. Error bars, standard error. *, P < 0.05; 
**, P < 0.01 (paired t test). (top) Expression of WRN and DNA2 after shRNA knockdown. (C) Co-IP experiments in HEK293T cells transfected with empty vec-
tors, Flag-DNA2, or Strep-HA-WRN. Cells were treated with 4 mM HU (3 h) where indicated. Whole-cell extracts were analyzed before (input) and after IP. 
(D) Statistical analysis of IdU tracts from RECQ1/DNA2-codepleted U-2 OS cells complemented with WT, ATPase-deficient (K671E), or nuclease-deficient 
(D294A) DNA2, when indicated. (E) Statistical analysis of IdU tracts from RECQ1-depleted WS cells complemented with WT, ATPase-deficient (K577M), 
or nuclease-deficient (E84A) WRN. Whiskers in D and E indicate the 10th and 90th percentiles. ns, not significant; ****, P < 0.0001 (Mann-Whitney 
test). n ≥ 300 tracts scored for each dataset shown in D and E.
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Figure 6. DNA2 resects reversed replication 
forks. (A) Electron micrograph of a partially 
single-stranded (left) and entirely double-
stranded (right) reversed fork observed on 
genomic DNA upon HU-treatment. The black 
arrow points to the ssDNA region on the re-
versed arm. Inset, magnified four-way junction 
at the reversed replication fork. D, Daughter 
strand; P, Parental strand; R, Reversed arm. 
(B) Frequency of fork reversal and ssDNA 
composition of the reversed arms in RECQ1- 
or DNA2-depleted U-2 OS cells treated with 
HU (left) or in unperturbed conditions (right). 
The percentage values are indicated on the 
top of the bar. “# RI” indicates the number of 
analyzed replication intermediates. Data in B 
are reproduced with very similar results in at 
least one independent experiment.
WRN-codepletion did not cause a further increase in reversed 
fork frequency, thus supporting our conclusion that DNA2 and 
WRN work together in reversed fork processing (Fig. S3 A).
Next, we evaluated the single-strand composition of the 
regressed arms. To measure ssDNA, we carefully inspected 
the frequency and length of ssDNA regions on the regressed 
arms by detecting local difference in filament thickness. 
DNA2 depletion led to a higher frequency of reversed forks 
with a dsDNA arm—and a corresponding decrease of partially 
or entirely single-stranded reversed forks—in both RECQ1-
proficient and deficient cells (Fig. 6). Thus, DNA2-mediated 
resection is directed to completely or partially digest one 
strand of the reversed arm leading to reversed forks that are 
either entirely single stranded or have a protruding ssDNA 
tail. However, prolonged stalling by HU was associated with 
accumulation of postreplicative ssDNA gaps on replicated 
duplexes, which was maximal in RECQ1-depleted cells and 
suppressed by DNA2 depletion (Fig. S3, B and C). Conse-
quently, ssDNA gaps may reflect additional activity of the 
same nucleolytic apparatus along the postreplicated duplexes 
or restart of partially resected reversed forks.
As an alternative readout for DNA2-dependent resection, 
we examined the phosphorylation status of RPA and the check-
point kinase Chk1 (Zeman and Cimprich, 2014). DNA2 deple-
tion caused a reduction in RPA and Chk1 phosphorylation in both 
RECQ1-proficient and RECQ1-deficient U-2 OS cells, suggest-
ing that the DNA2-dependent resection of nascent strands might 
also contribute to checkpoint activation (Fig. S3 D).
RAD51 promotes DNA2-dependent 
degradation of reversed replication forks
The central recombinase factor RAD51 is directly implicated in 
reversed fork formation upon genotoxic stress (Zellweger et al., 
2015). Thus, we investigated whether RAD51 depletion may 
affect the reversed fork processing activity of DNA2. We found 
that RAD51 knockdown largely prevents DNA2 nucleolytic 
processing both in RECQ1 proficient and RECQ1-deficient 
cells (Fig. 7 A). Genetic knockdown–rescue experiments 
confirmed that expression of exogenous RAD51 in RAD51- 
depleted U-2 OS cells restored the fork processing phenotype 
(Fig. 7 B). These results indicate that DNA2-dependent nucleolytic 
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Figure 7. RAD51 promotes DNA2-depedent 
degradation of reversed replication forks.  
(A) Representative IdU tracts in RECQ1-, RAD51-, 
or RECQ1/RAD51-codepleted U-2 OS cells 
(out of 2 repeats). Above, RECQ1 and RAD51 
expression after siRNA knockdown RAD51-
WT are U-2 OS cells stably expressing siRNA 
resistant exogenous RAD51. (B) Representa-
tive IdU tracts in U-2 OS cells expressing exog-
enous RAD51 (out of 2 repeats). n ≥ 300 tracts 
scored for each dataset shown in A and B.
processing is specifically targeted to reversed fork structures 
because it is not detected in a genetic background that prevents 
reversed fork formation—i.e., RAD51 knockdown.
DNA2 preferentially degrades reversed 
fork structures with a 5-to-3 polarity
The notion that DNA2 end resection has a preferential polarity 
in vivo is consistent with biochemical studies showing that even 
though DNA2 has the intrinsic capacity to degrade both 5- and 
3-terminated ssDNA, RPA enforces a primarily 5-to-3 end-
resection bias (Cejka et al., 2010; Niu et al., 2010; Nimonkar et al., 
2011). Thus, we set up new biochemical assays to test whether 
human DNA2 prefers four-way junction substrates—i.e., re-
versed replication forks—versus linear DNA duplexes and 
whether it degrades these substrates with a 5-to-3 polarity in 
the presence of RPA (Fig. 8, A and B). The sequences of the 
four arms of the four-way junction substrates are mutually 
heterologous to prevent four-way junction branch migration. 
DNA2-degraded four-way junction substrates more efficiently 
than linear dsDNA duplexes, with 20 nM DNA2 required to de-
grade 60% of the four-way junction substrates versus only 
30% of the linear duplex (Fig. 8 C). Importantly, supplement-
ing the reaction with RPA greatly stimulated the degradation 
activity of human DNA2 (Fig. 8 D and Fig. S4 A). Additional 
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Figure 8. Human DNA2 preferentially degrades branched 
DNA in a 5-3 direction in reactions stimulated by WRN. 
(A) Degradation of a four-way junction by human DNA2 
(hDNA2) in the presence of hRPA (native 6% polyacryl-
amide gel) (B) Experiment as in A, but with dsDNA. 
(C) Quantitation of data from A and B. Averages shown ± 
SEM; n = 2. (D) DNA degradation is stimulated by 
hRPA. The data points from +hRPA condition are the 
same as in C. Averages shown ± SEM; n = 2. (E) Quan-
titation of degradation of a 3 or 5 ssDNA-tailed three-
way junction by hDNA2. The reactions were performed in 
3 mM magnesium acetate and 22.3 nM hRPA. Averages 
shown ± SEM; n = 2. (F) Kinetics of degradation of a four-
way junction by hDNA2 (9 nM) in the presence of hRPA 
(denaturing 20% polyacrylamide gel). The substrate was 
labeled at the 5 end (*). D294A, nuclease-dead variant 
of hDNA2. (G) Experiment as in F, but using a four-way 
junction labeled at the 3 end. (H) Quantitation of DNA 
cleavage near (less than 15 nt) a 5 or 3 DNA end from 
experiments of F and G. Averages shown ± SEM; n = 2. 
(I) WRN and hDNA2 degrade four-way junction DNA in a 
synergistic manner. Reactions with indicated hDNA2 
and/or WRN concentrations and 65 nM hRPA were ana-
lyzed on a 6% native polyacrylamide gel. Heat, partially 
heated DNA substrate indicating the positions of DNA 
unwinding intermediates. (J) Quantitation of four-way junc-
tion and dsDNA degradation by human EXO1 (hEXO1). 
Averages shown ± SEM; n = 2.
experiments using either 5-end or 3-end 32P-labeled four-way 
junctions confirmed that human DNA2 had a strong 5-to-3 
bias in end resection in the presence of RPA (Fig. 8, E–H; and 
Fig. S4, B and C). Catalytically dead DNA2 D294A had no 
capacity to degrade DNA, showing that the nuclease activity 
is inherent to WT DNA2 (Fig. 8 F). The same results were 
recapitulated using purified yeast DNA2 (Fig. S5, A–F). Inter-
estingly, addition of the ATPase-deficient RECQ1 mutant 
(RECQ1-K119R) to the reaction mix significantly inhibited 
the four-way junction degradation activity of human DNA2 
(Fig. S4, D and E). These results suggest that the binding of 
RECQ1 to stalled replication forks limits the fork processing 
 o
n
 M
arch 2, 2015
jcb.rupress.org
D
ow
nloaded from
 
Published March 2, 2015
JCB • volume 208 • numBer 5 • 2015 556
DNA2 function during DNA replication is vital for main-
tenance of genome stability (this study; Duxin et al., 2012; 
Karanja et al., 2012). These findings indicate that the controlled 
DNA2-dependent degradation of reversed replication forks is a 
physiologically relevant mechanism to provide resistance to 
prolonged genotoxic treatments. This mechanism is distinct 
from the pathological MRE11-dependent degradation of stalled 
replication intermediates detected in the absence of crucial 
Fanconi Anemia (FA)/HR factors (Schlacher et al., 2011, 2012; 
Hashimoto et al., 2012; Ying et al., 2012).
We find that depletion of the central recombinase factor 
RAD51 prevents nascent strand degradation. This finding, coupled 
with the recent observation that RAD51 is directly implicated in 
reversed fork formation (Zellweger et al., 2015), reinforce our con-
clusion that the DNA2-dependent pathway starts from the reversed 
arm of stalled replication forks and acts downstream of the 
RAD51-mediated replication fork reversal. Given that RAD51 is 
required for reversed fork formation (Zellweger et al., 2015), we 
speculate that the MRE11-dependent pathway is only uncovered in 
the absence of fork reversal—i.e., via a perturbation in RAD51 
function—and likely attacks unprotected and nonreversed forks 
upon prolonged stalling. A crucial challenge for future studies will 
be to investigate why we do not observe a contribution of the 
MRE11 pathway in nascent strand degradation upon RAD51 
depletion. It is tempting to speculate that RAD51 depletion might 
interfere with MRE11-dependent fork processing, in addition to 
preventing fork reversal. Conversely, perturbation of RAD51 
function—e.g., via BRCA2 depletion (Schlacher et al., 2011)—
might be sufficient to prevent fork reversal—hence DNA2- 
dependent degradation—but still allow residual RAD51 loading 
to promote MRE11-dependent degradation.
Our DNA fiber analysis suggests that DNA2 degrades 
stalled replication intermediates beyond the maximum length 
of the reversed arms measured by EM (up to several kilobases). 
A possible interpretation of these results is that after the initial 
DNA2/WRN-mediated regressed arm degradation is complete, 
other nucleolytic activities or DNA2 itself may codegrade both 
sides of the replication fork, thus leading to extensive degra-
dation events detectable by DNA fibers. In this scenario, our 
EM images likely represent snapshots of the “slow steps” of 
this reaction—i.e., the DNA2/WRN-mediated degradation of 
the regressed arms—resulting in the drastic increase in reversed 
fork frequency observed in the absence of DNA2. Once the 
regressed arm has been resolved, the nucleolytic degradation 
might quickly proceed to degrade nascent strands behind the 
junction—as suggested by the DNA2-dependent increase in 
ssDNA gaps behind the observed forks—finally leading to re-
annealing of the parental strands and backtracking of the fork 
(Fig. S3 E). A new reversal event may occur when this extensive 
degradation leads to asymmetric ssDNA accumulation at the fork 
(Zellweger et al., 2015), resetting the backtracked fork to the slow 
step of the process. However, fork backtracking is only one possi-
ble model to explain the extensive degradation detected by DNA 
fibers and further work would be required to uncover additional 
nucleolytic activities that might be involved in this process.
Biochemical studies suggested that Schizosaccharomyces 
pombe Dna2 cleaves the leading and lagging reversed strands of 
activity of DNA2, as inferred by our cellular studies. However, 
we cannot rule out the possibility that the inhibitory effect ob-
served in the biochemical assays is simply associated with com-
petition for substrate recognition between the two proteins. In 
agreement with our in vivo data, we show that WRN promoted 
the degradative capacity of DNA2 on nicked, gapped, or four-
way junction substrates (Fig. 8 I and Fig. S4, F and G); similar 
behavior was observed when yeast Dna2 was coupled with the 
Sgs1 helicase (Fig. S5, G and H). DNA was degraded by WRN 
and DNA2 in a remarkably synergistic manner: 5 nM concen-
tration of either WRN or DNA2 alone led only to a minor DNA 
unwinding/degradation (Fig. 8 I, lanes 2 and 8). When com-
bined, both enzymes completely degraded the four-way junc-
tion DNA (Fig. 8 I, lane 5). In contrast, no such synergy was 
observed when human DNA2 was combined with the noncog-
nate yeast meiotic Mer3 helicase (Fig. S4 H), suggesting that 
the species-specific interaction between DNA2 and WRN re-
sults in a vigorous DNA degradation. Similarly, WT RECQ1 
did not promote DNA degradation by DNA2 (Fig. S4 I).
On the basis of our results that DNA2 does not share the 
same function of EXO1 in reversed fork processing, we decided to 
compare the end-resection activities of human DNA2 and human 
EXO1 using the four-way junction substrates. EXO1—unlike 
DNA2—degraded both four-way junction substrates and linear 
duplexes with equal efficiency (Fig. 8 J and Fig. S4, J and K). The 
use of yeast variants of Dna2 and Exo1 yielded analogous results 
(Fig. S5, I–K). Collectively, these studies further implicate DNA2, 
and its nuclease activity, in reversed replication fork degradation—
that is specifically stimulated by WRN—and point to an important 
difference in substrate preference between DNA2 and EXO1. 
Moreover, the polarity of reversed fork degradation by DNA2 
measured in the presence of RPA displays the same bias antici-
pated from the EM analysis of the replication intermediates.
Discussion
The present work uncovers a new mechanism for reversed fork 
processing and restart that requires the coordinated activities of 
the human DNA2 nuclease and WRN helicase (Fig. 9). The 
DNA2-dependent end resection leads to partially single-stranded 
reversed forks and is required for efficient replication fork re-
start under conditions of persistent replication blockage. WRN 
interacts with DNA2 and its ATPase activity is needed for 
DNA2-dependent degradation, presumably to transiently open 
the dsDNA arm of the reversed replication forks.
To date, we have identified two mechanisms of reversed 
replication fork resolution, one dependent on RECQ1 ATPase 
and branch migration activity (Berti et al., 2013) and the other on 
DNA2 nuclease and WRN ATPase activity. Moreover, the DNA2/
WRN mechanism is tightly regulated by an ATPase-independent 
function of RECQ1 that might limit DNA2 activity by binding to 
reversed forks. Of note, our EM experiments show that reversed 
replication forks accumulate in RECQ1- and DNA2-depleted 
cells also in unperturbed conditions suggesting that fork reversal 
is remarkably frequent when DNA replication faces intrinsic rep-
lication fork obstacles, and that RECQ1 and DNA2 have a con-
served role in restarting reversed forks in unperturbed S-phase.
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depletion is consistent with observations that the deregulation 
of checkpoint activity leads to a large increase in the number of 
newly initiated origins (Couch et al., 2013). However, the extent 
of ATR activation does not necessarily reflect the amount of 
ssDNA detected at replication forks, whether at the junction, at 
ssDNA gaps, or at regressed arms (Zellweger et al., 2015). In 
light of these findings, we rather suggest that DNA2-dependent 
ATR activation may reflect DNA2 recruitment to the stalled 
forks per se, or subtle changes of fork architecture that are asso-
ciated with its recruitment but possibly escape our EM analysis. 
This interpretation is supported by the recent discovery that 
yeast Dna2 has a direct role in Mec1 activation (the ortholog of 
human ATR), independent from its nuclease or helicase activity 
(Kumar and Burgers, 2013). Of note, the increased origin firing 
frequency observed upon DNA2 depletion is not associated to a 
parallel increase in the frequency of termination events (Fig. S1 A) 
possibly because the defects in replication fork restart associated 
a model replication fork with similar efficiency in the absence of 
replication protein A (Hu et al., 2012). However, it is likely that 
only the 5-to-3 directionality is important in vivo, because RPA 
is known to stimulate the 5-to-3 and inhibit the 3-to-5 nuclease 
activity of yeast DNA2 (Cejka et al., 2010; Niu et al., 2010). In 
agreement with this conclusion, our biochemical data show that 
DNA2-dependent end resection proceeds with a 5 to 3 polarity 
in the presence of RPA. Moreover, our EM experiments clearly 
show that DNA2 depletion affects the frequency of reversed forks 
that are either entirely or partially single-stranded supporting the 
notion that DNA2-dependent degradation of reversed forks oc-
curs with a preferential polarity in vivo.
The resection activity of human DNA2 was postulated to 
activate the ATR/Chk1 checkpoint under conditions of replica-
tion stress (Karanja et al., 2012). Indeed, we find that DNA2 de-
pletion prevents ATR checkpoint activation after HU treatment. 
Moreover, the increased origin firing observed upon DNA2 
Figure 9. Schematic model for the combined 
roles of DNA2 and WRN in reversed fork pro-
cessing. DNA2 and WRN functionally interact 
to process reversed forks. DNA2 degrades 
reversed forks with a 5-to-3 polarity. WRN 
ATPase activity assists DNA2 degradation pos-
sibly by promoting the opening of the reversed 
arm of the fork. RECQ1 limits DNA2 activity 
by an ATPase-independent function. Branch 
migration factors specifically recognize the 
partially resected reversed forks to promote 
fork restart. Alternatively, the newly formed 3  
overhang of the reversed fork invades the 
duplex ahead of the fork, resulting in Holliday 
junction structures that can be resolved by spe-
cific resolvases or dissolvases to promote fork 
restart. Gray box, RECQ1 can independently 
restart reversed forks by virtue of its ATPase 
and branch migration activity.
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specific genetic backgrounds. For example, MRE11 degrades 
stalled replication intermediates only in a BRCA2-deficent back-
ground, as already discussed (Schlacher et al., 2011). Moreover, 
the cleavage of unresolved replicative intermediates by the 
structure-specific MUS81 endonuclease is a late response to 
replicative stress, which becomes activated only when other 
attempts to overcome stalled replication have been exhausted 
(Hanada et al., 2007; Franchitto et al., 2008). Thus, MUS81 
might still resolve reversed replication forks as a back-up sys-
tem to unlink sister chromatids and facilitate mitotic segregation 
in the absence of DNA2 or WRN.
Collectively, these studies highlight a new important 
mechanism for the recovery from replication blockage. This 
mechanism relies on the DNA2-dependent processing of re-
versed forks—leading to ssDNA stretches on the regressed 
arms—which appear to promote efficient fork restart. A possi-
ble explanation for the need of partially single-stranded DNA 
structures to promote fork restart is that they represent a key in-
termediate to activate an HDR-like mechanism of reversed fork 
restart, as recently proposed in S. pombe (Carr and Lambert, 
2013). In particular, the newly formed 3 overhang of the re-
versed fork might invade the duplex ahead of the fork resulting 
in Holliday junction structures that can be resolved by specific 
resolvases or dissolved by the combined action of the BLM 
helicase (Sgs1 in yeast) and the type I topoisomerase TOP3 
(Fig. 9). Alternatively, resumption of DNA replication might be 
obtained by reverse branch migration, where the partially re-
sected reversed fork structures might be specifically recognized 
by a motor protein—e.g., SMARCAL1 (Béous et al., 2013) or a 
human RecQ helicase—to promote the branch migration-assisted 
reestablishment of a functional replication fork.
Materials and methods
Cell lines, culture conditions, and reagents
U-2 OS, HEK 293, and Werner Syndrome fibroblast (AG11395) cells were 
grown in DMEM supplemented with 10% FBS at 37°C in 5% CO2. HCT116 
cells were grown in McCoy’s 5A medium supplemented with 10% FBS. 
CldU, IdU, BrdU, hydroxyurea, mitomycin C, camptothecin, tamoxifen, pu-
romycin, and hygromycin were obtained from Sigma-Aldrich.
DNA2 conditional knockout HCT116 cells
To examine the response of cells to the complete absence of DNA2, we used 
a DNA2 conditional knockout cell line where exon 2 of the DNA2 gene is 
deleted (Karanja et al., 2014). The colorectal carcinoma HCT116 cell line 
carries 3 copies of DNA2 due to a duplication on chromosome 10. Two 
chromosomal copies were disrupted using rAAV-mediated gene targeting 
technology and exon 2 of the third allele was replaced with a conditional 
exon where the exon was flanked by loxP sites (DNA2flox//). To create 
a conditional cell line these cells were stably transduced with a tamoxifen 
(4-OHT)-inducible Cre recombinase. Thus, the cell line is viable and can be 
propagated. The addition of tamoxifen to the culture media leads to excision 
of the endogenous DNA2 and the generation of a true DNA2-null cell. Com-
plete loss of DNA2 occurs after 72 h of tamoxifen treatment. However, the 
DNA fiber experiments were performed after 40 h of tamoxifen treatment to 
have enough S-phase cells for DNA labeling.
Antibodies
Anti-DNA2 rabbit polyclonal (ab96488; 1:1,000), anti-MUS81 mouse 
monoclonal (ab14387; 1:1,000), and anti-CldU/BrdU rat monoclonal 
(ab6326; 1:6) antibodies (all from Abcam); anti-CtIP rabbit polyclonal 
(A300-488A; 1:1,000), anti-EXO1 rabbit polyclonal (A302-639A; 
1:1,000), anti-pRPA32 (S4/S8) rabbit polyclonal (A300-245A; 1:1,000), 
and anti-pRPA32 (S33) rabbit polyclonal (300-246A; 1:2,000; all from 
with DNA2 depletion limit the number of termination events 
even under conditions of increased origin firing.
WRN plays an important—albeit mechanistically ill- 
defined—role in the recovery from replication blockage, and 
mutations in the WRN gene are linked to the cancer predisposi-
tion disorder Werner Syndrome (Sidorova et al., 2008; Murfuni 
et al., 2012). Our studies infer that the high genomic instability 
of WRN-deficient cells may result from aberrant processing of 
reversed replication intermediates. In particular, given the con-
solidated role of WRN at difficult-to-replicate regions—e.g., 
telomeres and fragile sites (Crabbe et al., 2004; Murfuni et al., 
2012)—we speculate that WRN, in conjunction with DNA2, is 
required to process reversed forks arising spontaneously at 
these genomic loci. Biochemical studies pointed to a putative 
role of WRN in fork reversal and/or restart by showing that 
WRN efficiently promotes both the formation and restoration 
of oligonucleotide-based reversed fork substrates (Machwe 
et al., 2011). We show that WRN ATPase activity is needed for 
the DNA2-dependent degradation of reversed replication forks. 
Our interpretation for the role of WRN ATPase activity is that 
it facilitates DNA2-dependent degradation of the reversed forks 
by transiently opening the dsDNA arm of the reversed fork. 
This mechanism is reminiscent to the DNA2-dependent mecha-
nism of DSB resection where the yeast Sgs1 helicase is required 
to transiently open the DNA duplex to generate a 5 ssDNA tail 
that is in turn degraded by DNA2 (Zhu et al., 2008; Cejka et al., 
2010; Niu et al., 2010). We suggest that WRN is the functional 
homologue of Sgs1 in mammalian cells, at least in the context 
of DNA2-dependent reversed replication fork processing. How-
ever, BLM was also shown to interact and cooperate with DNA2 
to resect dsDNA ends in vitro opening the possibility that other 
human RecQ helicases might substitute for WRN, depending 
on the nature of the DNA lesion being processed or the particu-
lar cellular context (Nimonkar et al., 2011; Sturzenegger et al., 
2014). This mechanism seems to be well-conserved throughout 
evolution because it is highly reminiscent of the stalled fork 
processing pathway described in E. coli where the RecJ nucle-
ase cooperates with bacterial RecQ to process blocked replication 
intermediates (Courcelle et al., 2003). In addition, the prokary-
otic RecBCD helicase-nuclease plays an important role in re-
secting replication forks after reversal (Seigneur et al., 1998) 
and DNA2 is of the same family of nucleases as RecB. Whether 
the DNA2/WRN-mediated resection activity can degrade addi-
tional stalled replication intermediates other than reversed forks 
is worth future investigation.
EXO1, MRE11, and CtIP play central roles in DNA repair 
and are also implicated in the recovery from replication fork 
blockage (Cotta-Ramusino et al., 2005; Schlacher et al., 2011; 
Yeo et al., 2014). None of these nucleases, however, partici-
pates in the DNA2-dependent processing of reversed replica-
tion forks pointing to a specific role of DNA2 that, unlike 
its function in DSB resection, is not shared by other nucleases. 
A possible interpretation of these results is that the reversed 
forks are characterized by a particular structure of the terminal 
end that does not require the trimming activity of other nucle-
ases to promote DNA2-dependent resection. However, some of 
these nucleases might still be able to access stalled forks under 
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were kind gifts from Dr. Pietro Pichierri (Insituto Superiore di Sanità, Rome, 
Italy). All transfections were done with Lipofectamine 2000 (Life technolo-
gies Catalog no: 11668027). An shRNA targeting luciferase (5-ACGCT-
GAGTACTTCGAAATGT-3) was used for control shRNA experiments. The 
silencer select negative control (Life technologies, Catalog no. 4390843) or 
an siRNA targeting luciferase (5-CGUACGCGGAAUACUUCGA-3) were 
used for control siRNA experiments, as indicated. Lentiviral mediated shRNA 
depletions were achieved using the following sequences cloned into the 
pLKO.1 lentiviral shRNA expression vector: BLM (5-CGAAGGAAGTTGTAT-
GCACTA-3), WRN (5-GCTGGCAATTACCAGAACAAT-3), and MUS81 
(5-CACGCGCTTCGTATTTCAGAA-3). The procedure for lentiviral genera-
tion and transduction has been described (Berti et al., 2013). Transduced U-2 
OS cells were selected with 6 µg/ml puromycin. siRNA-mediated depletions 
were achieved using the following siRNAs from Invitrogen: DNA2 (5-AUA-
GCCAGUAGUAUUCGAU-3), CtIP (5-CGAAUCUUAGAUGCACAAA-3), 
EXO1 (Invitrogen-HSS113557), and RAD51 (Invitrogen-1299001). In brief, 
siRNAs were transfected using Lipofectamine RNAiMAX (Life Technologies) 
following the manufacturer’s protocol. MRE11 (5-GAAAGGCUCUAUC-
GAAUGU-3) and RECQ4 (SMART pool) siRNAs were from Dharmacon 
and were transfected as previously described (Thangavel et al., 2010).
Microfluidic-assisted DNA fiber stretching
For DNA replication fork restart analysis, asynchronous cells were pulse-
labeled with 50 µM CldU for 20–30 min. 2 mM HU, 300 nM MMC, or 
150 nM CPT was added to the CldU containing media and incubated for the 
indicated times. Cells were washed three times with medium and released 
with 50 µM IdU for 40 min. For nascent strand degradation analysis, asyn-
chronous cells were pulse-labeled with 50 µM IdU for 45 min, washed 
three times with medium, incubated with 4 mM HU, 100 nM CPT, 200 nM 
MMC, or medium for times indicated. The pulse-labeled cells were trypsin 
collected and lysed in agarose plugs to prevent any mechanical breakage 
of replication tracts. Microfluidic platform for stretching the high-molecular 
weight DNA, coverslips, immunostaining and image acquisition of replica-
tion tracts were performed as described (Sidorova et al., 2009; Berti et al., 
2013). In brief, polydimethylsiloxane (PDMS) stamps with microchannels 
were Oxygen plasma treated and reversibly sealed to the silanized cover-
slips. High-molecular weight DNA was loaded and stretched by capillary 
force into the microchannels. PDMS stamps were peeled-off and coverslips 
were left drying overnight. For immunostaining, DNA-stretched coverslips 
were denatured (2.5N HCL for 45 min), neutralized (0.1 M sodium borate 
and 3 washes with PBS), blocked (5% BSA and 0.5% Tween 20 in PBS for 
30 min), incubated with primary antibodies (Anti-IdU/BrdU or both anti-
IdU/BrdU and anti-CldU/BrdU for 30 min), washed (1% BSA and 0.1% 
Tween 20 in PBS, 3 times 5 min each) and incubated with secondary anti-
bodies (anti–mouse Alexa Fluor 488-conjugated, or both anti–mouse Alexa 
Fluor 488–conjugated and anti–rat Alexa Fluor 594–conjugated for 1 h). 
Washed slides were mounted in prolong gold anti-fade reagent (Life Tech-
nologies) and images were sequentially acquired (for double-label) with 
LAS AF software using TCS SP5 confocal microscope (Leica). A 63×/1.4 
oil immersion objective was used. Images were captured at room tempera-
ture. n ≥ 300 fiber tracts scored for each dataset. The DNA tract lengths 
were measured using ImageJ and the pixel length values were converted 
into micrometers using the scale bars created by the microscope. Statistical 
analysis was done using GraphPad Prism.
Clonogenic survival assay
Colony-forming assays were performed as previously described (Franken 
et al., 2006). In brief, 1,000 cells were plated per well and treated on the 
next day with 4 mM HU for 3, 6, and 8 h or 100 nM CPT for 6 h. Colonies 
were fixed, stained, and quantified 10 d after release from genotoxic stress. 
The plating efficiency and survival fraction were calculated as previously 
described (Franken et al., 2006). In brief, colonies were counted using an 
inverted stereomicroscope and the plating efficiency was calculated using 
the following formula: Plating Efficiency (PE) = (no. of colonies formed/no. of 
cells seeded) × 100%. From the plating efficiency, the surviving fraction (SF) 
was calculated as: SF = (no. of colonies formed after treatment/no. of cells 
seeded) × PE. The experiments were performed in triplicate and the statistical 
analysis was performed using GraphPad Prism.
Western blotting
Cells were washed with PBS and lysed either in standard RIPA buffer (PBS, 
1% NP-40, 0.5% sodium deoxycholate, 0.1% SDS, 10 µg/ml aprotinin, 
10 µg/ml PMSF, 1 mM Na3VO4, and 1 mM NaF) or MCL buffer (50 mM 
Tris, pH 8.0, 5 mM EDTA, 0.5% NP-40, 100 mM NaCl, 2 mM DTT, and 
freshly added protease and phosphatase inhibitors from Roche (1 tablet/10 ml 
of buffer). Cell lysates were resolved by SDS-PAGE and transferred to 
Bethyl); anti-WRN rabbit polyclonal (NB100-471; 1:1,000); and anti-
MRE11 rabbit polyclonal (NB100-142; 1:2,000; Novus); anti-RAD51 (H-92) 
rabbit polyclonal (sc-8349; 1:1,000) and anti-RECQ1 rabbit polyclonal 
(sc-25547; 1:2,000) from Santa Cruz; anti-rat Alexa (594-A11007; 
1:1,000); and anti–mouse Alexa Flour (488-A11001; 1:1,000; Invitro-
gen); anti-rabbit (31460; 1:10,000; Thermo Fisher Scientific); anti-tubulin 
mouse monoclonal (T5168; 1:5,000; Sigma-Aldrich); anti-IdU/BrdU 
mouse monoclonal (347580; 1:6) from BD; anti-Chk1 mouse monoclonal 
(sc-8408; 1:1,000; Santa Cruz Biotechnology, Inc.); anti-p-Chk1 (S345) 
rabbit monoclonal (2348; 1:1,000; Cell Signaling Technology); anti-RPA32 
mouse monoclonal (NA19L; 1:1,000) from EMD Millipore; anti-RECQ1 
rabbit polyclonal, raised against residues 634–649 of human RECQ1, is 
custom made (Mendoza-Maldonado et al., 2011); anti-BLM rabbit poly-
clonal, raised against residues 1–449 of human BLM (Wu and Hickson, 
2003), was a gift from I. Hickson (University of Copenhagen, Copenha-
gen, Denmark); and anti-RECQ4 rabbit polyclonal, raised against residues 
60–111 of human RECQ4 (Yin et al., 2004), was a gift from W. Wang 
(National Institute on Aging, Baltimore, MD).
Recombinant proteins
Yeast Dna2 was expressed in yeast WDH668 strain from pGAL:DNA2 
vector (Budd et al., 2000) and purified as previously described (Levikova 
et al., 2013). In brief, the cells were lysed and Dna2 was purified by 
affinity chromatography on Ni-NTA agarose (QIAGEN) and anti-Flag M2 
affinity gel (Sigma-Aldrich). Yeast RPA was expressed in yeast BJ5464 
strain containing three plasmids coding for Rfa1, Rfa2, and Rfa3 and 
purified as previously described (Kantake et al., 2003). In brief, the cells 
were lysed and yeast RPA was purified by affinity on ssDNA cellulose 
column (USB corporation) and by ion exchange chromatography using 
HiTrap Q column (GE Healthcare). Human DNA2 was expressed in Sf9 
cells from a pFastBac:hDNA2 vector (polyhedrin promoter) provided by 
J. Campbell (Masuda-Sasa et al., 2006). The soluble extracts were obtained 
by salt extraction as previously described for Sgs1 (Cejka and Kowalc-
zykowski, 2010). The subsequent purification of hDNA2 was performed 
as previously described for yeast Dna2 (Levikova et al., 2013) by affinity 
chromatography using Ni-NTA agarose (QIAGEN) and Anti-Flag M2 
affinity gel (Sigma-Aldrich). Human RPA was expressed from p11d-tRPA 
vector (Henricksen et al., 1994) in BL21 E. coli cells and purified as 
described (Henricksen et al., 1994). In brief, hRPA was first bound to 
HiTrap Blue column (GE healthcare) and then to HiTrap Q column. The 
sequence coding for yeast Mer3 helicase was amplified from yeast genomic 
DNA (SK1 strain) using primers Mer3FO (5-GCGCGCGGGCCCATGAAAA-
CAAAGTTTGATCGCCTCGGTACAGGAAAAAGAAGTAGACCCTCTC-
CAAATAATATTGACTTTAACGACCAG-3) and Mer3RE (5-CGCGCGCTC-
GAGTTCAAACTCTATATCGGAAC-3). The PCR product was digested 
with ApaI and XhoI restriction endonucleases (both from New England 
Biolabs) and cloned into corresponding sites in pFB-MBP-Sgs1-his after the 
polyhedrin promoter, creating pFB-MBP-Mer3-his vector. Mer3 was then 
expressed in Sf9 cells and purified using affinity chromatography as 
previously described for Sgs1 (Cejka and Kowalczykowski, 2010). In 
brief, MBP-tagged Mer3 was first bound to amylose resin (New England 
Biolabs), eluted and digested with PreScission protease to cleave the MBP 
tag. Mer3 was further purified by affinity on Ni-NTA agarose (QIAGEN) 
exploiting the 10x His-tag at its C-terminus. Sequence information is available 
on request.
Genetic knock-down-rescue experiments
RECQ1, DNA2, and RAD51 genetic knockdown-rescue experiments were 
performed using the procedure described (Berti et al., 2013; Yata et al., 
2012). In brief, RECQ1 is depleted using the pLKO.1-puro-shRECQ1 (5-GAG-
CTTATGTTACCAGTTA-3) construct and rescue experiments are performed 
using the shRNA resistant pIRES-RECQ1-WT or K119R (ATPase dead) con-
structs as described (Berti et al., 2013). DNA2 is depleted using an siRNA 
targeting the 3UTR of DNA2 (5-CAGUAUCUCCUCUAGCUAG-3). At 
least one isoform of DNA2 is not targeted by this sequence. DNA2 rescue 
experiments are performed using the pBabe-hygro-3xFLAG-DNA2 WT, 
D294A (Nuclease dead), or K671E (helicase dead) constructs. RAD51 
is depleted using siRNAs targeting the 3UTR (5-GACUGCCAGGAU-
AAAGCUU-3 and 5-GUGCUGCAGCCUAAUGAGA-3) in U-2 OS stable 
cell lines expressing WT RAD51 as described (Yata et al., 2012). WRN 
depletions were achieved using pRS-puro-shWRN (5-AGGCAGGTGTAG-
GAATTGAAGGAGATCAG-3; sequence ID: TI333414) and exogenous 
expression is done with the shRNA resistant Flag-pCMVTag2B-WRN WT 
or K577M (helicase dead) constructs. Constructs for WRN depletion and 
overexpression of WT WRN and ATPase-deficient WRN (WRN-K577M) 
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pyruvate kinase, 1 nM DNA substrate (molecules), and recombinant pro-
teins, as indicated. The reactions were assembled on ice and incubated 
for 30 min at 30°C for yeast proteins and at 37°C for human proteins. Un-
less indicated otherwise, RPA was present in the reactions at saturating 
concentrations corresponding to a threefold excess over DNA, assuming 
all DNA was single-stranded and a DNA-binding site size of 25 nt for 
hRPA and of 20 nt for yRPA. The reactions were terminated by adding 5 µl 
Stop buffer (150 mM EDTA, 2% SDS, 30% glycerol, and 0.01% bromo-
phenol blue), incubated for 30 min at room temperature and separated on 
polyacrylamide gels in TBE buffer under native conditions. Alternatively, 
for denaturing conditions, the reaction were terminated by adding 15 µl 
Formamide stop buffer (95% (vol/vol) formamide, 20 mM EDTA, 0.01% 
bromophenol blue), denatured by heating at 95°C for 5 min and sepa-
rated on 20% denaturing polyacrylamide gels in TBE buffer. Gels were 
fixed, dried, exposed to a storage phosphor screen, and analyzed on 
Typhoon phosphor imager (GE Healthcare).
Online supplemental material
Fig. S1 shows quantification of stalled forks, new origins, and termination 
events in DNA2-depleted cells upon genotoxic stress induction, as well as 
the statistical analysis of IdU tracts from RECQ1-, DNA2-, WRN-, RECQ1/
DNA2-, RECQ1/WRN-, WRN/DNA2-, and RECQ1/WRN/DNA2-depleted 
U-2 OS cells. Fig. S2 shows the IdU tract length distribution in BLM- and 
RECQ4-depleted cells, respectively, as well as statistical analysis of IdU 
tracts from RECQ1/WRN-codepleted cells complemented with WT WRN 
or with ATPase-deficient WRN. Fig. S3 shows additional EM analysis, as 
well as the Western blot analysis of ATR-checkpoint activation in RECQ1- 
and/or DNA2-depleted U-2 OS cells. Fig. S4 shows additional biochemi-
cal analysis of substrate specificity of human DNA2 and human EXO1. 
TFig. S5 shows biochemical assays of substrate specificity of yeast Dna2 
and yeast Exo1. Online supplemental material is available at http://www 
.jcb.org/cgi/content/full/jcb.201406100/DC1.
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Co-immunoprecipitation experiments
HEK293T cells were transfected with empty vectors, FLAG-DNA2, and Strep-
HA-WRN by calcium phosphate. 48 h after transfection, cells were treated 
with 4 mM HU for 3 h, lysed in benzonase lysis buffer (50 mM Tris-HCl, 
pH 7.5, 75 mM KCl, 2 mM MgCl2, 20 mM NaF, 10 mM -glycerophosphate, 
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(Sigma-Aldrich) to digest genomic DNA. KCl and EDTA concentrations were 
adjusted to 120 and 3 mM, respectively, and lysates were centrifuged at 
14,000 rpm for 30 min. Immunoprecipitations of clarified lysates were per-
formed with FLAG M2 or HA affinity agarose resin (Sigma-Aldrich) overnight 
at 4°C. Beads were washed 5 times with wash buffer (50 mM Tris-HCl, 
pH 7.5, 150 mM KCl, 3 mM EDTA, 2 mM MgCl2, 20 mM NaF, 10 mM 
-glycerophosphate, 0.2 mM Na3VO4, and 0.2% Triton X-100) and bound 
proteins were eluted by boiling in SDS-PAGE sample buffer.
EM analysis of genomic DNA in mammalian cells
EM analysis of replication intermediates has been described in detail (Ray 
Chaudhuri et al., 2012; Neelsen et al., 2014), including a description of the 
important parameters to consider specifically for the identification and the 
scoring of reversed forks (Neelsen et al., 2014). In brief, 5–10 × 106 U-2 
OS cells were harvested and genomic DNA was cross-linked by two rounds 
of incubation in 10 µg/ml 4,5,8-trimethylpsoralen (Sigma-Aldrich) and 
3 min of irradiation with 366 nm UV light on a precooled metal block. Cells 
were lysed and genomic DNA was isolated from the nuclei by proteinase K 
(Roche) digestion and phenol-chloroform extraction. DNA was purified by 
isopropanol precipitation, digested with PvuII HF in the proper buffer for 3–5 h 
at 37°C, and replication intermediates were enriched on a benzoylated 
naphthoylated DEAE–cellulose (Sigma-Aldrich) column. EM samples were 
prepared by spreading the DNA on carbon-coated grids in the presence of 
benzyl-dimethyl-alkylammonium chloride and visualized by platinum rotary 
shadowing. Images were acquired on a transmission electron microscope 
(JOEL 1200 EX) with side-mounted camera (AMTXR41 supported by AMT 
software v601) and analyzed with ImageJ (National Institutes of Health).
Preparation of oligonucleotide-based DNA substrates
DNA oligonucleotides were purchased from Microsynth and 32P-labeled 
either at the 5 terminus with [-32P] ATP and T4 polynucleotide kinase (New 
England Biolabs), or at the 3 end with [-32P] cordycepin-5-triphosphate 
and terminal transferase (New England Biolabs) according to manufacturer’s 
instructions. Unincorporated nucleotides were removed using MicroSpin 
G25 columns (GE Healthcare). The substrates were prepared by heating the 
respective oligonucleotides at 95°C and gradually cooling to room temperature. 
The following oligonucleotides were used for the preparation of the four- 
way junction (X12-3 TOP L, HJ 1, HJ 2, and HJ 3), three-way junction with 
3 tail (X12-3 TOP L, HJ 1, HJ 2Sb, and HJ 3), three-way junction with 5 ssDNA 
tail (X12-3 TOP L, HJ 1S, HJ 2, and HJ 3), nicked four-way junction (X12-3 
TOP L, HJ 1, HJ 2Sa, HJ 2Sb, and HJ 3), replication fork (X12-3 TOP L, HJ 
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GCGACTTACGTTCCATCGCTAGGTTATTTTTTTTTTTTTTTTTTT-3 X12-3 HJ 1 
(93 nt), 5-AAAAAAAAAAAAAAAAAAATAACCTAGCGATGGAACGTA-
AGTCGCGATGGGCTTAACTAGGATGCTACTGGCCCCGAATCAACCGT-
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ATCGTCTATGACGTC-3.
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 Figure S1.  DNA2 and WRN function in stalled fork processing. (A, left) Schematic of DNA ﬁ ber tract analysis. (right) Quantiﬁ cation of red tracts (stalled 
forks), green tracts (new origins), and contiguous red–green–red tracts (termination events). Proper quantiﬁ cation of stalled forks is complicated by the fact 
that termination events might also lead to red tracts if termination occurs before the addition of the second label. Mean shown,  n = 3. Error bars, standard 
error. ns, not signiﬁ cant; *, P < 0.05; **, P < 0.01; ***, P < 0.001 (paired Student’s  t test). (B, left) Expression of Flag-tagged WT (DNA2-WT) or nuclease-
dead (DNA2-D294A) DNA2 in DNA2-depleted U-2 OS cells. (right) Quantiﬁ cation of stalled forks in DNA2-depleted cells expressing DNA-WT or DNA2-
D294A. Mean shown,  n = 3. Error bars, standard error. ns, not signiﬁ cant; *, P < 0.05 (paired  t test). (C, top) Expression of RECQ1, WRN, DNA2, and 
tubulin in U-2 OS cells transfected with the indicated shRNA or siRNA. (middle) Statistical analysis of IdU tracts from U-2 OS cells depleted for the indicated 
proteins in the presence of 4 mM HU. (bottom) Statistical analysis of IdU tracts from U-2 OS cells depleted for the indicated proteins in the absence of drug 
treatment. Whiskers indicate the 10th and 90th percentiles. ns, not signiﬁ cant (Mann-Whitney test).  n ≥ 300 scored for each dataset. (D, top) Expression 
of WRN after WRN knockdown and representative ﬁ ber tract images in Luc- and WRN-depleted U-2 OS cells. Bar, 15 μm. Representative IdU tracts in 
WRN-depleted U-2 OS cells in the presence or absence of HU (out of 2 repeats;  n ≥ 700 scored for each dataset). 
JCB S2 
 Figure S2.  BLM or RECQ4 depletion does not have a signiﬁ cant effect on stalled fork processing. (A) Representative IdU tracts in Luc-, RECQ1-, BLM-, or 
RECQ1/BLM-codepleted U-2 OS cells in the presence of HU (out of 2 repeats;  n ≥ 300 scored for each dataset). (top) Expression of RECQ1, BLM and tubu-
lin in U-2 OS cells transfected with indicated shRNA. (B) Representative IdU tracts in control, RECQ1-, RECQ4-, or RECQ1/RECQ4-codepleted U-2 OS cells 
in the presence of HU (out of 2 repeats;  n ≥ 350 scored for each dataset). (top) Expression of RECQ1, RECQ4 and tubulin in U-2 OS cells transfected with 
indicated shRNA. (C) Expression of RECQ1, DNA2-WT, DNA2-K671E, and DNA2-D294A in U-2 OS cells transfected with the indicated shRNA or siRNA. 
(D) Expression of RECQ1, WRN-WT, WRN-K577M, and WRN-E84A in WS cells. (E) Statistical analysis of IdU tracts from RECQ1-, WRN-, or RECQ1/
WRN-codepleted U-2 OS cells. The RECQ1/WRN-codepleted cells were complemented with WT or ATPase-deﬁ cient (K577M) WRN, where indicated. 
Whiskers indicate the 10th and 90th percentiles. ns, not signiﬁ cant; ****, P < 0.0001 (Mann-Whitney test). (F) Expression of RECQ1, WRN-WT, and 
WRN-K577M in U-2 OS cells transfected with the indicated shRNA. 
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 Figure S3.  DNA2 promotes ssDNA gap accumulation on replicated duplexes and the ATR-mediated checkpoint activation. (A) Frequency of fork reversal 
and ssDNA composition of the reversed arms in WRN- and/or DNA2-depleted U-2 OS cells in the presence and absence of HU. The percentage values 
are indicated on the top of the bar. “# RI” indicates the number of analyzed replication intermediates. (B) Representative electron micrographs of replication 
forks displaying ssDNA gaps on the replicated duplexes or at the replication fork junction observed on genomic DNA in shRECQ1 U-2 OS cells upon HU-
treatment. The black arrows point to ssDNA gaps. D, Daughter strand; P, Parental strand. (C) Statistical distribution of ssDNA gaps on newly replicated du-
plexes in RECQ1- and/or DNA2-depleted U-2 OS cells treated with HU (top) or in unperturbed conditions (bottom). “# RI” is the number of analyzed 
replication intermediates. (D) Western blot analysis of ATR-checkpoint activation (pChk1 and pRPA) in RECQ1- and/or DNA2-depleted U-2 OS cells with 
or without HU treatment. Total Chk1 and RPA level are displayed and used as loading control. (E) Schematic of the different structures detected by EM and 
DNA ﬁ bers. EM is a static method, which enriches for snapshots of the “slow steps” of a reaction (i.e., partially resected reversed forks). After fork restart, 
the nucleolytic degradation quickly proceeds to degrade nascent strands behind the junction. Reannealing of the parental strands leads to “backtracking” 
of the fork. A new reversal event arises as a consequence of asymmetric degradation, and thus ssDNA accumulation in proximity to the fork. Backtracking 
is easily detected by DNA ﬁ ber, but not by EM because a reversed fork formed after degradation and backtracking is indistinguishable from the original re-
versed fork present before initial degradation. 
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 Figure S4.  Human DNA2 but not EXO1 preferentially degrades branched DNA. (A) Degradation of a four-way junction by hDNA2 without human RPA 
(hRPA). Reaction products were separated on a native polyacrylamide gel (6%); *, position of the  32 P label. (B) Degradation of a three-way junction with 
a 5  ssDNA tail by hDNA2 in the presence of hRPA (22.3 nM). Reaction products were separated on a native polyacrylamide gel (6%); *, position of the 
 32 P label. (C) Same experiment as in B, but with a junction containing a 3  ssDNA tail. (D) RECQ1 K119R (ATPase-dead) inhibits four-way junction degrada-
tion by hDNA2. Increasing concentrations of RECQ1 (K119R) were preincubated with the substrate, and then hDNA2 (20 nM) was added to the reaction 
mixture. All reactions contained hRPA (65 nM). Reaction products were separated on a native polyacrylamide gel (6%); *, position of the  32 P label. 
(E) Quantitation of data from D. Averages shown ± SEM,  n = 2. (F) Synergistic action of hDNA2 and WRN on a nicked plasmid based DNA substrate. 
The reactions contained 614 nM hRPA and were incubated at 37°C for 60 min. Products were separated on a 1% agarose gel and stained with GelRed. 
WRN helicase promotes degradation of nicked DNA by hDNA2. (G) Same experiment as in F, but with a gapped DNA substrate. (H) Degradation of a 
four-way junction by hDNA2 and  S. cerevisiae Mer3. hDNA2 only degrades ssDNA unwound by Mer3, no synergy in DNA degradation was observed. 
All reactions contained hRPA, and were analyzed on a native polyacrylamide gel (6%). (I) Degradation of four-way junction by hDNA2 is not stimulated 
by WT hRECQ1. All reactions contained hRPA (65 nM). Reaction products were separated on a native polyacrylamide gel (6%). (J) Degradation of a four-
way junction by hEXO1. Reaction products were separated on a native polyacrylamide gel (6%); *, position of the  32 P label. (K) Same experiment as in J, 
but with dsDNA. 
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 Figure S5.  Yeast Dna2 but not Exo1 preferentially degrades branched DNA. (A) Degradation of a four-way junction by yDna2 in presence (left) or absence (right) 
of yeast RPA (yRPA). Reactions were separated on a native polyacrylamide gel (6%), *, position of the  32 P label. (B) Experiment as in A, but with dsDNA and yRPA. 
(C) Yeast Dna2 preferentially degrades four-way junctions in the presence of yRPA. Quantitation of data from A and B. Averages shown ± SEM;  n = 2. (D) yRPA 
promotes DNA degradation by yDna2. Quantitation of data from A. The data points representing the degradation of a four-way junction in the presence of yRPA 
are identical to those from C. Mean shown ± SEM,  n = 2. (E) Yeast Dna2 preferentially degrades branched structures over dsDNA. Quantitation of degradation 
of various DNA substrates as indicated (cartoons on the right) by yDna2 WT in presence of yRPA. Averages shown ± SEM;  n = 2. (F) Denaturing 20% polyacryl-
amide gel showing that nuclease-dead yDna2 E675A variant does not degrade the four-way junction substrate. (G) Synergistic action of yDna2 and Sgs1 helicase 
on a nicked dsDNA plasmid based substrates. The reactions contained 770 nM yRPA and were incubated at 30°C for 60 min before being separated on a 1% 
agarose gel containing GelRed. (H) Experiment as in G, but with gapped DNA substrate. (I) Degradation of a four-way junction by yExo1 in the presence (right) 
or absence (left) of yRPA. (J) Same experiment as in I, but with dsDNA. (K) Quantitation of data from I and J. Averages shown ± SEM,  n = 2. 
